Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry

Journal of Virology

Volumn 72, Issue 7, 1998, Pages 5425-5432

  Owen, Sherry M ^a   Ellenberger, Dennis ^a   Rayfield, Mark ^a   Wiktor, Stefan ^b   Michel, Philippe ^c   Grieco, Michael H ^d   Gao, Feng ^e   Hahn, Beatrice H ^e   Lal, Renu B ^a,f  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b Projet Retro CI   (South Africa)

^c CENTRE DE RECHERCHES   (France)

^d ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; RECEPTOR SUBTYPE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS STRAIN;

EID: 0031747199     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.7.5425-5432.1998     Document Type: Article

References (68)

1. Albert, J., P. Stalhandske, S. Marquina, J. Karis, R. A. Fouchier, E. Norby, and F. Chiodi. 1996. Biological phenotype of HIV type 2 isolates correlates with V3 genotype. AIDS Res. Hum. Retroviruses 12:821-828.
2. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, and MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
3. Alkhatib, G., F. Liao, E. A. Berger, J. M. Farber, and K. W. C. Pedan. 1997. A new SIV co-receptor, STRL33. Nature 388:238.
4. Andreasson, P. A., F. Dias, A. Naucler, S. Andersson, and G. Biberfeld. 1993. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS 7:989-993.
5. Berger, E. A. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11(Suppl. A):S3-S16.
6. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-832.
7. Brelot, A., N. Heveker, O. Pleskoff, N. Sol, and M. Alizon. 1997. Role of the first and third extracellular domains of CXCR4 in human immunodeficiency virus coreceptor activity. J. Virol. 71:4744-4751.
8. Bron, R., P. J. Klasse, D. Wilkinson, P. R. Clapham, A. Pelchen-Matthews, C. Power, T. N. C. Wells, J. Kim, S. C. Peiper, J. A. Hoxie, and M. Marsh. 1997. Promiscuous use of the CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. J. Virol. 71:8405-8415.
9. Chen, Z., P. Zhou, D. D. Ho, N. R. Landau, and P. A. Marx. 1997. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:2705-2714.
10. Cheng-Mayer, C., R. Liu, N. R. Landau, and L. Stamatatos. 1997. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J. Virol. 71:1657-1661.
11. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
12. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1996. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 70:9055-9059.
13. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
14. Cocchi, F., A. L. DeVico, L. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
15. Cocchi, F., A. L. DeVico, L. Garzino-Demo, A. Cara, R. C. Gallo, and P. Lusso. 1996. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1244-1247.
16. Connor, R. I., K. E. Sheridan, O. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-628.
17. De Cock, K. M., G. Adjorlolo, E. Ekpini, T. Sibailly, J. Kouadi, M. Maran, K. Brattegaard, K. M. Vetter, R. Doorly, and H. D. Gayle. 1993. Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic. JAMA 270:2083-2086.
18. De Jong, J.-J., A. De Ronde, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66:6777-6780.
19. de Jong, J.-J., J. Goudsmit, W. Keulen, B. Klaver, W. Krone, M. Tersmette, and A. de Ronde. 1992. Human immunodeficiency virus type I clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:757-765.
20. Deng, D., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, R. E. Sutton, D. R. Littman, and N. L. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-665.
21. Deng, H., D. Unutmaz, V. N. KewalRamani, and D. R. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300.
22. Dittmar, M. T., A. McKnight, G. Simmons, P. R. Clapham, R. A. Weis, and P. Simmonds. 1997. HIV-1 tropism and coreceptor use. Nature 385:495-496.
23. Donnelly, C., W. Leisenring, P. Kanki, T. Awerbuch, and S. Sandberg. 1993. Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal. Bull. Math. Biol. 55:731-743.
24. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smith, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptor CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
25. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
26. Edinger, A. L., A. Amedee, K. Miller, B. J. Doranz, M. Endres, M. Sharon, M. Samson, Z.-H. Lu, J. E. Clements, M. Murphy-Corb, S. C. Peiper, M. Parmentier, C. C. Broder, and R. W. Doms. 1997. Differential utilization of CCR5 by macrophage tropic and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA 94:4005-4010.
27. Endres, M. J., P. R. Clapham, M. Marsh, M. Ahuja, J. D. Turner, A. McKnight, J. F. Thomas, B. Stoebenau-Haggarty, S. Choe, P. J. Vance, T. N. C. Wells, C. A. Power, S. S. Sutterwala, R. W. Doms, N. R. Landau, and J. A. Hoxie. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-756.
28. Farzan, M., H. Choe, K. Martin, L. Marcon, W. Hofman, G. Karlson, Y. Sun, P. Barrett, N. Marchand, N. Sullivan, N. Gerard, C. Gerard, and J. Sodroski. 1997. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:405-411.
29. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-877.
30. Feorino, P. M., V. S. Kalyanaraman, H. W. Haverkos, C. D. Cabradilla, D. T. Warfield, H. W. Jaffe, and A. K. Harrison. 1984. Lymphadenopathy associated virus infection of a blood donor-recipient pair with acquired immunodeficiency syndrome. Science 255:69-72.
31. Gao, F., L. Yue, D. L. Robertson, S. C. Hill, H. Hui, R. J. Biggar, A. E. Neequaye, T. M. Whelan, D. D. Ho, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1994. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J. Virol. 68:7433-7447.
32. Hahn, B. H. 1994. Viral genes and their products, p. 21-43. In S. Broder, T. Merigan, and D. Bolognesi (ed.). Textbook on AIDS medicine. Williams & Wilkins, Baltimore, Md.
33. Heredia, A., V. Vallejo, V. Soriano, J. S. Epstein, and I. K. Hewlett. 1997. Chemokine receptors and HIV-2. AIDS 11:1198-1199.
34. Higgins, D. G., A. J. Bleasby, and R. Fuchs. 1992. CLUSTAL V: improved software for multiple alignment on a microcomputer. Comp. Appl. Biosci. 5: 593-604.
35. Higgins, D. G., and P. M. Sharp. 1988. Clustal: a package for performing multiple sequence alignments on a microcomputer. Gene 73:237-244.
36. Hill, C. M., H. Deng, D. Unutmaz, V. N. KewalRamani, L. Bastiani, M. K. Gorny, S. Zolla-Pazner, and D. R. Littman. 1997. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this Chemokine receptor. J. Virol. 71:6296-6304.
37. Kanki, P. J., K. U. Travers, S. M'Boup, C. C. Hsieh, R. G. Marlink, A. Gueye-N'Diaye, T. Siby, I. Thior, M. Hernandez-Avila, J. L. Sankale, I. N'Doye, and M. E. Essex. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946.
38. Kimura, M. 1983. The neutral theory of molecular evolution. Cambridge University Press, Cambridge, England.
39. Kirchhoff, F., S. Pohlmann, M. Hamacher, R. E. Means, T. Kraus, K. Uberla, and P. Di Marizio. 1997. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J. Virol. 71: 6509-6516.
40. Kozak, S. L., E. J. Platt, N. Madani, F. E. Ferro, Jr., K. Peden, and D. Kabat. 1997. CD4. CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J. Virol. 71:873-882.
41. Kuiken, C. L., J.-J. de Jong, E. Baan, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 66:4622-1627.
42. Liao, F., G. Alkhatib, K. W. C. Peden, G. Sharma, E. A. Berger, and J. M. Farber. 1997. STRL33, a new novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T-cell-tropic HIV-1. J. Exp. Med. 185:2015-2023.
43. Liu, R., W. A. Oaxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. McDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
44. Maddon, P. J., J. S. McDougal, P. R. Clapham, A. G. Dalgleish, S. Jamal, R. A. Weiss, and R. Axel. 1988. HIV infection does not require endocytosis of its receptor CD4. Cell 54:865-874.
45. Markovitz, D. M. 1993. Infection with the human immunodeficiency virus type 2. Ann. Intern. Med. 118:211-218.
46. Marlink, R. G., D. Ricard, S. M. Boup, P. J. Kanki, J. L. Romet-Lemonne. I. N. Doye, K. Diop, M. A. Simpson, F. Greco, M. J. Chou, V. Degruttola, C. C. Hsieh, C. Boye, F. Barin, F. Denis, M. F. McLane, and M. Essex. 1988. Clinical, hematological, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res. Hum. Retroviruses 4:137-148.
47. McDougal, J. S., S. M. Kennedy, J. M. Sligh, S. P. Cort, A. Mawle, and J. K. A. Nicholson. 1986. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382-385.
48. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizer, F. Arenzana-Seisdedos, O. Schwartz, J. Heard, I. Clark-Lewis, D. F. Legler, M. Loetscher, M. Baggiolini, and B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature 382:833-835.
49. Pepin, J., G. Morgan, D. Dunn, S. Gevao, M. Mendy, I. Gaye, N. Scollen, R. Tedder, and H. Whittle. 1991. HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 5:1165-1172.
50. Potempa, S., L. Picard, J. D. Reeves, D. Wilkinson, R. A. Weiss, and S. J. Talbot. 1997. CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR4 in fusion and entry. J. Virol. 71:4419-4424.
51. Premack, B. A., and T. J. Schall. 1996. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2:1174-1178.
52. Quinn, T. C. 1994. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc. Natl. Acad. Sci. USA 91:2407-2414.
53. Reeves, J. D., A. McKnight, S. Potempa, G. Simmons, P. W. Gray, C. A. Power, T. Wells, R. A. Weiss, and S. J. Talbot. 1997. CD-4 independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR3 and V28 for entry. Virology 231:130-134.
54. Robertson, D. L., B. H. Hahn, and P. M. Sharp. 1995. Recombination in AIDS viruses. J. Mol. Evol. 40:249-259.
55. Romieu, I., R. Marlik, P. Kanki, S. M. Boup, and M. Essex. 1990. HIV-2 link to AIDS in West Africa. J. Acquired Immune Defic. Syndr. 3:220-230.
56. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
57. Sattentau, Q. J., P. R. Clapham, R. A. Weiss, P. C. L. Beverley, L. Montagnier, M. F. Alhalabi, J.-C. Gluckman, and D. Klatzmann. 1988. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 2: 101-105.
58. Schuitemaker, H., M. Koot, N. A. Kootstra, M. W. Dercksen, R. E. de Goede, R. P. van Steenwijk, J. M. A. Lange, J. K. M. E. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
59. Shioda, T., J. A. Ley, and C. Cheng-Mayer. 1992. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:9434-9438.
60. Simmons, G., D. Wilkinson, J. D. Reeves, M. T. Dittmar, S. Beddows, J. Weber, G. Carnegie, U. Desselberger, P. W. Gray, R. A. Weiss, and P. R. Clapham. 1996. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:8355-8360.
61. Sol, N., F. Ferchal, J. Braun, O. Pleskoff, C. Treboute, I. Ansart, and M. Alizon. 1997. Usage of the coreceptors CCR-5, CCR3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J. Virol. 71:8237-8244.
62. Telesnitsky, A., S. Blain, and S. P. Goff. 1995. Assays for retroviral reverse transcriptase. Methods Enzymol. 262:347-351.
63. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184-188.
64. Valentin, A., J. Albert, M. Fenyo, and M. Asjo. 1994. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68:6684-6689.
65. Weiss, R. A. 1993. Cellular receptors and viral glycoproteins involved in retrovirus entry, p. 1-108. In J. A. Levy (ed.), The Retroviridae, vol. 2. Plenum Press, New York, N.Y.
66. Xiao, L., S. M. Owen, I. Goldman, A. A. Lal, J. J. deJong, J. Goudsmit, and R. B. Lal. 1998. CCR5-coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 240:83-92.
67. Xiao, L., D. L. Rudolph, S. M. Owen, T. J. Spira, and R. B. Lal. Adaptation to promiscuous usage of CC and CXC chemokine coreceptors in vivo correlates with HIV-1 disease progression. Submitted for publication.
68. Zhang, L., Y. Huang, T. He, Y. Cao, and D. D. Ho. 1996. HIV-1 subtype and second receptor use. Nature 383:768.